Skip to main content

H.R. 449

Referred to Committee

Synthetic Drug Awareness Act of 2018

Introduced 1/11/2017•115th Congress•House

Latest Action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

6/13/2018 • Senate

Summary

Synthetic Drug Awareness Act of 2017

This bill requires the Surgeon General to report to Congress on the public health effects of the increased use since January 2010 by individuals who are 12 to 18 years old of drugs developed and manufactured to avoid control under the Controlled Substances Act (e.g., synthetic marijuana, also known as "spice," and synthetic amphetamines, also known as "bath salts").

Introduced in House • 1/11/2017

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Child healthCongressional oversightDrug trafficking and controlled substancesDrug, alcohol, tobacco use

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (48)

Party Breakdown

20
Democrats
28
Republicans
0
Independents

Sponsor

R[
Rep. Jeffries, Hakeem S. [D-NY-8]

Democrat • NY-8

Sponsored 1/11/2017

Cosponsors (47)

R[
Rep. Meehan, Patrick [R-PA-7]

R-PA-7

Joined 1/11/2017

R[
Rep. Gowdy, Trey [R-SC-4]

R-SC-4

Joined 1/11/2017

R[
Rep. Collins, Chris [R-NY-27]

R-NY-27

Joined 1/11/2017

R[
Rep. Butterfield, G. K. [D-NC-1]

D-NC-1

Joined 1/11/2017

RL

Bill Journey

Originated in the House

Introduced

January 11, 2017

Committee Review

April 25, 2018

Forwarded by Subcommittee to Full Committee (Amended) by Unanimous Consent .

Floor Debate

June 12, 2018

Passed Chamber

June 12, 2018

Other Chamber

President

Enacted into Law

Text Versions (3)

Referred in Senate6/13/2018
Engrossed in House6/12/2018
Introduced in House1/11/2017

Details

Bill TypeHR
Current StatusReferred to Committee
Cosponsors47